The topic of biologic therapy for IBD has been selected for this Focus ... or biologic agents once corticosteroids are indicated, to induce clinical remissions. Factors such as extensive disease ...

More clinical trials need to be carried out in order to find new agents as routine treatments for IBD patients. Considering the efficacy, indication and side effects of biological agents ...

Women aged 18 to 45 years with IBD were invited to complete a survey regarding knowledge, attitude, and beliefs about contraception.

Consecutive IBD patients initiating biological therapy because of active endoscopic disease ... All patients received drugs with standard dosage, according to the label. Blood samples were collected ...

Eli Lilly has received approval from the US Food and Drug Administration (FDA) for Omvoh (mirikizumab-mrkz) to treat moderately to severely active Crohn's disease in the adult population. This is the ...

On this day Dr. Wolf is seeing his patient Katie for her Crohn's disease— a type of IBD that can affect the entire digestive tract but is most prevalent in the ...

However, only a subgroup of patients responds to therapy, highlighting the need to identify biomarkers for therapeutic response to allow personalised medicine in inflammatory bowel disease. Potential ...

Ulcerative colitis in children is often characterized by extensive colitis with a cumulative rate of colectomy up to 40% at 10 years. Scheduled combination therapy with anti-TNF (and pretreatment ...

If joint pain is related to IBD, biologic agents are among the treatment options. Physical therapy, and in rare cases, joint surgery may be needed to improve range of motion and reduce symptoms.

Mesoblast has gained US Food and Drug Administration (FDA) approval for its mesenchymal stromal cell (MSC) therapy ... and biologic-resistant inflammatory bowel disease. Other therapies, such ...